Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CISPLATIN Cause Nephropathy? 47 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Nephropathy have been filed in association with CISPLATIN (CISplatin). This represents 0.1% of all adverse event reports for CISPLATIN.

47
Reports of Nephropathy with CISPLATIN
0.1%
of all CISPLATIN reports
3
Deaths
24
Hospitalizations

How Dangerous Is Nephropathy From CISPLATIN?

Of the 47 reports, 3 (6.4%) resulted in death, 24 (51.1%) required hospitalization, and 1 (2.1%) were considered life-threatening.

Is Nephropathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 47 reports have been filed with the FAERS database.

What Other Side Effects Does CISPLATIN Cause?

Off label use (4,359) Disease progression (3,746) Neutropenia (3,095) Febrile neutropenia (3,010) Nausea (2,923) Drug ineffective (2,608) Thrombocytopenia (2,565) Anaemia (2,530) Vomiting (2,326) Diarrhoea (2,022)

What Other Drugs Cause Nephropathy?

LANSOPRAZOLE (1,332) OMEPRAZOLE (1,241) ESOMEPRAZOLE (1,151) EMTRICITABINE\TENOFOVIR DISOPROXIL (1,089) TENOFOVIR DISOPROXIL (1,033) PANTOPRAZOLE (892) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (618) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (342) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (300) DEXLANSOPRAZOLE (259)

Which CISPLATIN Alternatives Have Lower Nephropathy Risk?

CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE CISPLATIN vs CITALOPRAM CISPLATIN vs CITALOPRAM HYDROBROMIDE CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CISPLATIN vs CITICOLINE

Related Pages

CISPLATIN Full Profile All Nephropathy Reports All Drugs Causing Nephropathy CISPLATIN Demographics